Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Weekly dosing maintains therapeutic benefits while allowing your body to process and clear the compound systematically
Both medications use the same active ingredient and work in a similar way
Ensayos clave SURMOUNT-1/2/4/5 (peso), SURPASS 1-5 (DM2), SUMMIT (ICFEp), SURPASS-CVOT (MACE), SURMOUNT-OSA (apnea)
The analysis included data from 18,742 patients with type 2 diabetes mellitus (T2DM) receiving 5.0mg, 10.0mg, or 15.0mg once-weekly subcutaneous tirzepatide or 0.5mg, 1.0mg, or 2.0mg once-weekly subcutaneous semaglutide for at least 12 weeks
US$ 21.53
US$ 22.51
US$ 28.38
US$ 23.78
US$ 24.40
